Biotech Distilled
Substack ↗
Subscribe
Subscribe
Substack ↗
About
Research
Areas
Modalities
Phases
Targets
Catalysts
Filings
Track record
Movers
The Lead Compound
Home
›
Targets
› NCF1
NCF1
(1 companies · 1 programs)
Companies with an active program directed at NCF1.
Prime Medicine, Inc.
PRME
PM359
— Chronic Granulomatous Disease
Phase 1